- Home
- WTI vs AVIR Comparison
WTI vs AVIR Comparison
Compare WTI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTI
- AVIR
- Stock Information
- Founded
- WTI 1983
- AVIR 2012
- Country
- WTI United States
- AVIR United States
- Employees
- WTI N/A
- AVIR N/A
- Industry
- WTI Oil & Gas Production
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- WTI Energy
- AVIR Health Care
- Exchange
- WTI Nasdaq
- AVIR Nasdaq
- Market Cap
- WTI 250.5M
- AVIR 247.5M
- IPO Year
- WTI 2005
- AVIR 2020
- Fundamental
- Price
- WTI $1.85
- AVIR $3.37
- Analyst Decision
- WTI Strong Buy
- AVIR Hold
- Analyst Count
- WTI 1
- AVIR 1
- Target Price
- WTI $7.80
- AVIR $6.88
- AVG Volume (30 Days)
- WTI 2.6M
- AVIR 528.5K
- Earning Date
- WTI 03-04-2025
- AVIR 02-26-2025
- Dividend Yield
- WTI 2.16%
- AVIR N/A
- EPS Growth
- WTI N/A
- AVIR N/A
- EPS
- WTI N/A
- AVIR N/A
- Revenue
- WTI $537,256,000.00
- AVIR N/A
- Revenue This Year
- WTI $0.01
- AVIR N/A
- Revenue Next Year
- WTI $11.70
- AVIR N/A
- P/E Ratio
- WTI N/A
- AVIR N/A
- Revenue Growth
- WTI N/A
- AVIR N/A
- 52 Week Low
- WTI $1.33
- AVIR $2.75
- 52 Week High
- WTI $3.28
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- WTI 57.20
- AVIR 55.56
- Support Level
- WTI $1.72
- AVIR $3.11
- Resistance Level
- WTI $1.90
- AVIR $3.60
- Average True Range (ATR)
- WTI 0.10
- AVIR 0.13
- MACD
- WTI 0.04
- AVIR 0.00
- Stochastic Oscillator
- WTI 83.33
- AVIR 53.17
About WTI W&T Offshore Inc.
W&T Offshore Inc is an oil and gas exploration and production company. The company's exploration operations are focused in the Gulf of Mexico, where it drills for oil and gas. The company engages in both deepwater drilling and shallow-water shelf drilling. W&T Offshore extracts crude oil, natural gas, and natural gas liquids, which are then sold directly at the wellhead. Overall, crude oil accounts for the majority of company's revenue, with natural gas accounting for a much smaller portion.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).